Companies
Stay informed about the latest developments and news from cannabis companies with Business of Cannabis. Learn about new products, mergers and acquisitions, and more.
Companies · page 7
- Industry Trends
Organigram Acquires Sanity Group: When Big Tobacco Moves into Cannabis
By Dr Sebastian Marincolo, Director of Strategic Content & Editorial, Weed.de Canadian cannabis company Organigram Global has agreed to acquire Berlin’s Sanity Group for up to 227 million euros, financed in large part by a roughly 65 million Canadian dollar capital injection from its largest shareholder, British American Tobacco (BAT).
- Clinical Research
Ananda Pharma Cleared to Begin Dosing in NHS-Backed CBD Endometriosis Trial
Ananda Pharma has cleared the final regulatory hurdle needed to begin its ENDOCAN Phase 2 clinical trial, receiving approval from the MHRA and NHS Health Research Authority to commence dosing of its proprietary MRX1 CBD oral solution in women with endometriosis-associated pain.
- Industry Trends
The Scramble for Europe
Last month, the German cannabis market saw its most significant consolidation deal to date, as Canadian heavyweight Organigram announced plans to acquire Sanity Group in a deal worth up to €250m.
- Prescribers & Clinics
Evidena Care Launches Switzerland’s First Integrated Medical Cannabis Market Comparison Platform
Evidena Care, one of Switzerland’s leading specialised telemedicine providers for medical cannabis, has announced the launch of a nationwide online comparison platform for prescription-based medical cannabis products.
- M&A Activity
Curaleaf Laboratories and Sanity Group Announce Partnership to Advance Medical Cannabis Innovation in the UK
Curaleaf Laboratories, one of the UK-leading pharmaceutical-grade medical cannabis manufacturers, is delighted to announce a partnership with Berlin-based Sanity Group, a European life science company focused on cannabinoids and wellbeing products.
- Press releases
Why We Built PPX: From Advocacy to Growth
In 2017, when we launched Prohibition Partners, we set out with the goal to change the conversation around cannabis.
- Investment & Finance
Business Brief: Safe Harbor Capitalises on Rescheduling Momentum with Financial Ecosystem Offering
Cannabis fintech Safe Harbor Financial is positioning itself to capitalise on the regulatory tailwinds created by federal rescheduling, launching new service partnerships and renegotiating core banking agreements in a bid to fill the severe financial infrastructure gap in the US cannabis industry.
- M&A Activity
Business Brief: Argent Biopharma’s Revenues Drop, Outgoings Rise Ahead of AusCann Deal
Argent Biopharma, formerly MGC Pharmaceuticals, has entered 2026 in a precarious financial position, according to its recently published quarterly figures.
- Industry Trends
Access, Saturation, Consolidation: Why Denmark Foreshadows the Future of Europe’s Medical Cannabis Markets
As Europe’s medical cannabis markets continue to mature, an increasingly familiar pattern is beginning to emerge.
- Clinical Research
Can the Company That Built Australia’s Pastilles Market Do It Again in the UK?
Australia’s booming medical cannabis market, now the largest outside of North America, has seen a dramatic shift in consumer preference over the last two years.
- Investment & Finance
French Excellence at the Heart of a High-Capacity EU-GMP Site
PGP Farmer closes a €3m funding round to become a leading player in EU-GMP medical cannabis production in Europe French biotech company PGP Farmer unveils the closing of a €3 million funding round with private investors.
- Prescribers & Clinics
Collapsed Cannim Sees Liquidators Target $32m in Voidable Transactions as UK Creditors Face Enforcement Gap
Collapsed international cannabis operator Cannim has officially been placed into liquidation following a failed sales process, seeing its myriad of creditors vie for their share of the tens of millions of dollars now reportedly outstanding.
